Otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR(™) therapeutic protein, for relapsed or refractory NHL patients
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Scott C Stromatt Ajay K Gopal Ian W. Flinn Farrukh T Awan Stephen E. Spurgeon John C. Byrd Mark C. Lanasa |
| Publication date | August 22, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |